When they put Lovenox approval as 50% of their bonus plan, we'll know they actually have a high confidence in a near term approval.
What's their plan for future development and funding?
356, they're well behind their initial guidance on it. Its been a moving target. I think its an enormous undertaking reverse engineering a complex generic and a scalable, replicable mfg process, so this is to be expected. Characterizing is probably the easy part for mnta.
Market Data 
Markets 
AI
